Skip to content

Effect of Curcumin-Piperine (Compounds from turmeric and pepper) and Probiotics in patients with Knee Osteoarthritis

Effect of Curcumin-Piperine and Probiotic Supplementation in patients with Early Knee Osteoarthritis

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/07/043621
Enrollment
150
Registered
2022-07-01
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M170- Bilateral primary osteoarthritis of knee

Interventions

Intervention1: Curcumin-Piperine, Probiotics: Curcumin-Piperine (Compounds from turmeric and pepper (1500 mg per day of curcumin and 15 mg per day piperine) and Probiotics (Lactobacillus acidophilus L

Sponsors

University Grants Commission UGC NET JRFSRF Grant
Lead Sponsor
Sami Labs Limited
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Subjects with primary unilateral or bilateral knee osteoarthritis with radiographic evidence (Kellgren-Lawrence Grade I or II).

Exclusion criteria

Exclusion criteria: Female patients who are pregnant, lactating, planning to become pregnant, patients who are already taking anti-inflammatory supplements, patients suffering from chronic illnesses that could interfere with the study outcomes.

Design outcomes

Primary

MeasureTime frame
Pain reduction and functional improvement will be recorded as the primary outcome measures evaluated by the mean change from baseline to end of trial in the VAS (Visual Analogue Scale) pain score and total WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) Score. Timepoint: Baseline, 1 month, 2 month, End of Trial

Secondary

MeasureTime frame
WOMAC subscale score (pain, stiffness and physical function) , Improvement in biochemical parameters (for inflammation), Improvement in clinical parameters, Improvement in Physical function (as measured by 6MWT, TUG, chair stand test and stair climb test). Timepoint: Baseline, End of trial

Countries

India

Contacts

Public ContactAyesha Ashraf Kherani

College of Home Science, Nirmala Niketan

geetaibrahim@yahoo.com9820153902

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026